Jason Wittes
Stock Analyst at Roth Capital
(3.63)
# 832
Out of 4,981 analysts
63
Total ratings
50.91%
Success rate
7.86%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals | Initiates: Buy | $40 | $10.03 | +298.80% | 1 | Sep 4, 2025 | |
| SYK Stryker | Maintains: Buy | $405 → $456 | $383.34 | +18.95% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.16 | +640.74% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $5.78 | -6.57% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $3.89 | +311.31% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $14.93 | +47.35% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $71.27 | +1.02% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $4.61 | +138.61% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $58.74 | +95.78% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $9.44 | +281.36% | 1 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $11 | $7.11 | +54.71% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.07 | +834.58% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $92.47 | +8.14% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.85 | +75.44% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.57 | +473.25% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $31.72 | +136.44% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $15.26 | +44.17% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $103.08 | +16.41% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $147.44 | +39.72% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $212.61 | -31.80% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $15.77 | -4.85% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $12.15 | +1,546.09% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $32.16 | -19.15% | 1 | Feb 22, 2017 |
ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $10.03
Upside: +298.80%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $383.34
Upside: +18.95%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.16
Upside: +640.74%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $5.78
Upside: -6.57%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $3.89
Upside: +311.31%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $14.93
Upside: +47.35%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $71.27
Upside: +1.02%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.61
Upside: +138.61%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $58.74
Upside: +95.78%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $9.44
Upside: +281.36%
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.11
Upside: +54.71%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.07
Upside: +834.58%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $92.47
Upside: +8.14%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.85
Upside: +75.44%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.57
Upside: +473.25%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $31.72
Upside: +136.44%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $15.26
Upside: +44.17%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $103.08
Upside: +16.41%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $147.44
Upside: +39.72%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $212.61
Upside: -31.80%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $15.77
Upside: -4.85%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $12.15
Upside: +1,546.09%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $32.16
Upside: -19.15%